earned his PhD doctoral thesis in Organic Chemistry with honors and graduated at the University of Aix-Marseille III. In 1998, with Christophe Baralotto, his long-lasting partner in a number of ventures, he co-founded Provence Technologies. He is President of this privately-owned company and co-inventor of the patent on methylene blue. In 2007, he founded Provepharm which he is leading as President. The company was established as a supplement to Provence Technologies in order to create business value in pharmaceuticals out of a genuine synthesis route of Methylene Blue patented by Provence Technologies.
holds a PhD doctoral thesis in Organic Chemistry (specialty organic synthesis) which he earned at the University Joseph Fourier of Grenoble in 2001. He is the co-author of several publications relating to the multistep synthesis of natural alkaloids. Babak joined Provence Technologies as the Laboratory Manager in 2003. Today, Babak is the COO and CSO of the company.
Babak is the co-inventor of the patent on methylene blue.
earned his PhD doctoral thesis in Organic Chemistry at the University of Aix-Marseille III in 1997. In 1998, with Michel Feraud, his long-lasting partner in a number of ventures, he co-founded Provence Technologies. Since 2008 and further to the creation of Provence Technologies’ sister company Provepharm, Christophe has been holding the executive position of CFO for all the companies of the Group.